- Home
- SWIN vs GDTC Comparison
SWIN vs GDTC Comparison
Compare SWIN & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- GDTC
- Stock Information
- Founded
- SWIN 2017
- GDTC 2018
- Country
- SWIN Hong Kong
- GDTC Singapore
- Employees
- SWIN N/A
- GDTC N/A
- Industry
- SWIN
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- GDTC Health Care
- Exchange
- SWIN Nasdaq
- GDTC Nasdaq
- Market Cap
- SWIN 32.1M
- GDTC 28.0M
- IPO Year
- SWIN 2023
- GDTC 2023
- Fundamental
- Price
- SWIN $3.54
- GDTC $2.02
- Analyst Decision
- SWIN
- GDTC Buy
- Analyst Count
- SWIN 0
- GDTC 1
- Target Price
- SWIN N/A
- GDTC $5.00
- AVG Volume (30 Days)
- SWIN 280.3K
- GDTC 7.2K
- Earning Date
- SWIN 08-21-2025
- GDTC 01-01-0001
- Dividend Yield
- SWIN N/A
- GDTC N/A
- EPS Growth
- SWIN N/A
- GDTC N/A
- EPS
- SWIN N/A
- GDTC N/A
- Revenue
- SWIN $3,316,000.00
- GDTC $368,838.00
- Revenue This Year
- SWIN $29.79
- GDTC $5.37
- Revenue Next Year
- SWIN $54.60
- GDTC N/A
- P/E Ratio
- SWIN N/A
- GDTC N/A
- Revenue Growth
- SWIN N/A
- GDTC N/A
- 52 Week Low
- SWIN $1.16
- GDTC $1.20
- 52 Week High
- SWIN $4.40
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- SWIN 58.20
- GDTC 40.10
- Support Level
- SWIN $2.93
- GDTC $2.01
- Resistance Level
- SWIN $4.01
- GDTC $2.22
- Average True Range (ATR)
- SWIN 0.46
- GDTC 0.09
- MACD
- SWIN -0.05
- GDTC -0.02
- Stochastic Oscillator
- SWIN 41.50
- GDTC 5.88
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.